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The effector domain (ED) of the influenza virus virulence factor NS1 is capable
of interaction with a variety of cellular and viral targets, although regulation of
these events is poorly understood. Introduction of a W187A mutation into the
ED abolishes dimer formation; however, strand–strand interactions between
mutant NS1 ED monomers have been observed in two previous crystal forms. A
new condition for crystallization of this protein [0.1M Bis-Tris pH 6.0, 0.2M
NaCl, 22%(w/v) PEG 3350, 20 mM xylitol] was discovered using the hanging-
drop vapour-diffusion method. Diffraction data extending to 1.8 A˚ resolution
were collected from a crystal grown in the presence of 40 mM thieno[2,3-b]-
pyridin-2-ylmethanol. It was observed that there is conservation of the strand–
strand interface in crystals of this monomeric NS1 ED in three different space
groups. This observation, coupled with conformational changes in the interface
region, suggests a potential role for -sheet augmentation in NS1 function.
1. Introduction
The NS1 protein of influenza virus is an important virulence factor
and has been demonstrated to interact with a wide variety of viral
and cellular biomolecules (Hale, Randall et al., 2008). In particular,
crystallographic structures have been obtained of the N-terminal
RNA-binding domain (RBD) in complex with dsRNA (Cheng et al.,
2009) and of the C-terminal effector domain (ED) in complex with
the F2F3 portion of the cellular processing and specificity factor
CPSF30 (Das et al., 2008) and with the iSH2 domain of the PI
3-kinase regulatory subunit p85 (Hale, Kerry et al., 2010). Further-
more, both domains form homodimers in vitro (Bornholdt & Prasad,
2006; Chien et al., 1997; Hale, Barclay et al., 2008; Xia et al., 2009).
While the conformation of the RBD dimer appears to be conserved,
two forms of the ED dimer have been proposed: the strand–strand
dimer and the helix–helix dimer (Hale, Barclay et al., 2008; Xia et al.,
2009; Bornholdt & Prasad, 2006). The helix–helix dimer is present
in all wild-type NS1 ED structures (Kerry et al., 2011) and in the
structure of full-length NS1 (Bornholdt & Prasad, 2008). In contrast,
the canonical strand–strand dimer has only been observed in crys-
tallographic contacts in a few NS1 ED structures obtained using NS1
from the A/Puerto Rico/8/34 (PR8) strain. The structure of the full-
length NS1 protein from an H5N1 strain has also been reported to
exhibit this interface, although in a somewhat distorted form, leading
to claims that the strand–strand dimer is involved in NS1 oligomer-
ization (Bornholdt & Prasad, 2008). The introduction of a W187A
mutation into the ED induces a monomeric phenotype (Hale, Barclay
et al., 2008; Kerry et al., 2011; Xia & Robertus, 2010) and, intriguingly,
two crystal structures of the PR8 NS1 ED containing this mutation
also exhibit this strand–strand interface.
Although the NS1 ED is known to interact with several viral and
cellular factors, only two structures of NS1 in complex with another
protein have been solved. Therefore, the sites of many of the other
interactions are very poorly characterized. Recently, a new model for
NS1 regulation was proposed in which formation of the ED helix–
helix dimer regulates interactions between NS1 and other factors
(Kerry et al., 2011). In particular, it was observed that binding to
CPSF30 and PI-3-kinase were both incompatible with ED dimeriza-
tion and would require separation of the two monomers. At present
no function has been ascribed to the dimerized ED, although
disruption of this interface may interfere with binding to dsRNA
(Kerry et al., 2011; Wang et al., 2002). However, while the role of the
helix–helix interface in ED dimerization appears to be settled,
potential roles for the strand–strand interface remain to be explored.
Interestingly, formation of the helix–helix dimer leaves the strand–
strand interface available for other intermolecular interactions,
allowing the possibility of the formation of alternative -sheet
interactions.
In this paper, we report a third X-ray crystallographic structure of
the PR8 NS1 ED containing the W187A mutation. This structure is
highly homologous to the previous structures obtained using this
construct and conservation of the strand–strand packing interface
highlights a possible role for -sheet augmentation in NS1 function.
2. Experimental
The construction of the pRSFDuet plasmid expressing a His6-tagged
version of PR8 NS1 ED (W187A) (residues 73–230) has been
described previously (Kerry et al., 2011). The plasmid was trans-
formed into Escherichia coli Rosetta (DE3) expression strain
(Novagen) for protein expression. The transformed E. coli cells were
inoculated into Luria–Bertani (LB) medium with 50 mg ml1 kana-
mycin at 310 K. 1 mM isopropyl -d-1-thiogalactopyranoside (IPTG)
was added to induce protein expression when the optical density at
600 nm (OD600) of the culture reached 0.6. Cell culture continued for
16 h at 295 K before harvesting by centrifugation at 7000g for 20 min
at 277 K. The harvested pellet was resuspended in 20 ml phosphate-
buffered saline supplemented with 1 mM MgCl2, 20 mg ml
1 DNase
(Sigma), 200 mg ml1 lysozyme (Sigma) and protease-inhibitor
cocktail tablets (two tablets per 20 ml; Roche Diagnostics) and
incubated for 2 h at 295 K, after which the crude cell extract was
centrifuged at 20 000g for 15 min at 277 K. The supernatant was then
supplemented by the addition of 5 ml 2M NaCl and 0.5 ml 250 mM
imidazole before loading onto a 15 ml nickel column (GE Health-
care). Bound protein was eluted using 500 mM imidazole and then
dialysed for 16 h at 295 K against 200 mM NaCl, 50 mM Tris pH 7.4,
1 mM dithiothreitol, during which time cleavage of the His6 tag was
achieved by addition of 200 U tobacco etch virus protease (Invi-
trogen). Uncleaved protein was removed from the dialysed fraction
by loading it onto a 15 ml nickel column. The flowthrough fraction
was then pooled for gel filtration using a 120 ml HiLoad 16/60
Sephadex 75 column (GE Healthcare).
The purified PR8 NS1 ED (W187A) was pooled and concentrated
to 8.5 mg ml1 using a 5000 MWCO Vivaspin column (Sartorius).
Prior to screening for novel crystallization conditions, 40 mM
thieno[2,3-b]pyridin-2-ylmethanol and 2% dimethyl sulfoxide were
added to the purified protein. Screening was performed using the
sitting-drop vapour-diffusion method at 290 K with the commercial
kits Clear Crystal Strategy 1 and 2, Structure Screen 1 and 2
(Molecular Dimensions) and Classics II and PEGs II (Qiagen). After
one week, needle-shaped crystals were observed using Classics II
condition No. 71 (0.2MNaCl, 0.1M Bis-Tris pH 6.5, 25% PEG 3350).
This condition was selected for optimization by the hanging-drop
vapour-diffusion method with crystallization drops made up of 1 ml
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Table 1
Crystallographic summary.
Values in parentheses are for the highest resolution shell.
Protein PR8 NS1 72 W187A
Space group C2221
Unit-cell parameters (A˚) a = 32.0, b = 102.8, c = 67.4
Maximum resolution (A˚) 1.80 (1.83–1.80)
Unique reflections 9857
Completeness (%) 92.2 (52.4)
Mean I/(I) 50.1 (3.9)
Multiplicity 6.4
Rmerge (%) 0.048 (0.419)
VM (A˚
3 Da1) 2.12
Refinement
Protein atoms 918
Water atoms 81
Resolution range (A˚) 18–1.8
Rcryst (%) 19.4
Rfree (%) 24.9
Mean temperature factors (A˚2)
Protein 27.8
Waters 35.6
R.m.s.d. bond lengths (A˚) 0.007
R.m.s.d. bond angles () 1.054
Ramachandran favoured/outliers (%) 98.3/0
Figure 1
(a) Crystal structure of PR8 NS1 ED (W187A) described here (PDB entry 3rvc,
shown in green). A strand–strand packing interface is formed with a symmetry-
related molecule (shown in light grey). (b) Crystal-packing interactions formed
between the PR8 NS1 ED (W187A) structure 3rvc (shown in cyan) and symmetry-
related molecules (shown in magenta). The NS1 ED helix–helix dimer binding site
is exposed.
purified protein solution and 1 ml reservoir solution. The optimal
conditions for crystallization were found to be 0.2M NaCl, 0.1M Bis-
Tris pH 6.0, 22% PEG 3350, 0.02M xylitol. Crystals appeared after
4 d and reached their maximum size after 14 d.
Crystals were cryoprotected by transfer to a solution of 20%(w/v)
xylitol in crystallization buffer before data collection at 100 K. Data
were collected in-house (Rigaku–MSC MicroMax-007 HF X-ray
generator and Saturn 944+ CCD detector). Data processing and
scaling were performed using HKL-2000 (Otwinowski, 1993). The
previously obtained structure of PR8 NS1 ED (W187A) (PDB entry
3o9q; Kerry et al., 2011) was used for molecular replacement using
Phaser (McCoy et al., 2007) in the PHENIX package (Adams et al.,
2002). PHENIX and Coot (Emsley & Cowtan, 2004) were used to
refine the model, which was validated with MolProbity (Chen et al.,
2010). Data-collection and refinement statistics are shown in Table 1.
Figures were created using PyMOL (Schro¨dinger, 2010).
3. Results and discussion
The novel crystal form of PR8 NS1 ED (W187A) shows the / fold
common to all structures of NS1 ED (Bornholdt & Prasad, 2006;
Kerry et al., 2011). In contrast to the majority of NS1 structures, only
one molecule of PR8 NS1 ED (W187A) was present within the
asymmetric unit, although a strand–strand interface homologous
to those observed for previous structures obtained using this con-
struct was observed between symmetry-related monomers (Fig. 1a).
As expected from its monomeric form, the helix–helix dimer present
within all wild-type structures of NS1 was not observed in the crystal
lattice (Fig. 1b). This is in agreement with previous structures
obtained using this construct, which also lack the helix–helix dimer
interface (Kerry et al., 2011). Therefore, since the PR8 NS1 ED
W187A mutant is monomeric in vitro (Kerry et al., 2011), it appears
highly likely that the helix–helix dimer is the predominant interface
for ED homodimerization. However, it is intriguing to observe that
the strand–strand dimer is conserved among all three PR8 NS1 ED
(W187A) structures that have now been solved. Additionally, this
interface is also employed in two of the four wild-type PR8 NS1 ED
structures [PDB entries 2gx9 (Bornholdt & Prasad, 2006) and 3o9u
(Kerry et al., 2011)]. This is a remarkable coincidence, especially
considering that the crystals leading to these five structures belonged
to different space groups (P3221, P212121, C2221, P4322 and P64) and
that conservation between mutant and wild-type structures is not
observed for any other NS1 ED interface. Comparison of the strand–
strand dimers indicates two distinct orientations of the monomers
relative to one another (Supplementary Fig. 11). Although one
orientation predominates, the AF and BD dimers of 3o9u adopt a
slightly twisted arrangement, indicating that there may be some
flexibility in the contacts formed at this interface. The partial con-
servation of the strand–strand packing interface indicates that while it
may not allow ED dimerization, extension of the -sheet is a possible
method of interaction with cellular and viral binding partners.
Interestingly, this interface is not observed in other structures of the
NS1 ED, even when mutations preventing helix–helix dimerization
are introduced [e.g. W187Y (PDB entry 3kwi) and W187A (PDB
entry 3kwg); Xia & Robertus, 2010]. Therefore, it could be concluded
that any functional properties of this interface may vary between
influenza virus strains. Such strain-specificity has been observed for
some functions of NS1, most notably interaction with CPSF30, which
is associated with NS1s from H3N2 and H2N2 subtypes but not all
isolates of the H1N1 subtype (Kuo et al., 2010; Hale, Steel et al., 2010).
However, while the other NS1 ED solved from an H1N1 subtype
(A/California/07/09; PDB entry 3m5r; Center for Structural Geno-
mics of Infectious Diseases, unpublished work) does not exhibit a
strand–strand dimer, it does show antiparallel strand–strand inter-
actions via an alternative arrangement (Supplementary Fig. 21). In
structures of NS1 from PR8 the strand–strand dimer is formed by
residues 88–91 of the two monomers interacting with one another to
form a contiguous -sheet; however, in the case of 3m5r residues 80–
85 of chain A are sandwiched between residues 87–92 of chain G and
residues 86–89 of chain B. This variant on the -sheet augmentation
theme suggests that such interactions may not be restricted by the
sequences and arrangements observed in the strand–strand packing
interface.
Although the overall fold of the NS1 ED monomer is remarkably
well conserved, comparison of all of the ED monomers solved to date
indicates two regions of significant variation between the structures
(Fig. 2). One region that appears to be capable of adopting a variety
of positions is the 170-loop (residues 162–170), which is present at the
interface between the ED and the iSH2 domain of p85 and has also
been proposed to be a putative SH3-binding motif (Hale, Kerry et al.,
2010; Shin et al., 2007). While the structure of this loop is always well
ordered, the positions adopted vary between structures regardless of
the strain or subtype (Fig. 2, left insert). Flexibility in this region may
indicate a propensity for binding to a number of factors in addition to
p85, as several orientations may be required for different binding
events.
A second region of variance between NS1 ED monomers which
has been observed previously (Hale, Barclay et al., 2008) is the
N-terminus of the ED (up to residue 91) and the -hairpin loop
(140-loop) between the fourth and fifth -strands (residues 135–143)
(Fig. 2b, right insert). These residues appear to occupy one of two
conformations, for which the A chain of 2gx9 (Bornholdt & Prasad,
2006; 2gx9_A) and the A chain of 3d6r (Hale, Barclay et al., 2008;
3d6r_A) could be considered to be archetypical structures. Interest-
ingly, the position of this region does not appear to depend upon the
structural communications
860 Kerry et al.  NS1 effector domain Acta Cryst. (2011). F67, 858–861
Figure 2
Superposition of monomers of NS1 ED. The monomers are aligned with PR8 NS1
ED structure 2gx9_A. Monomers participating in strand–strand interactions are
coloured red, whilst those not participating in such interactions are coloured blue.
Inserts highlight areas of increased variability within the NS1 ED structure: left,
170-loop; right, N-terminus and 140-loop.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: HV5191).
sequence or strain of the ED crystallized, but rather on whether
a strand–strand contact is formed within the crystal lattice. For
example, the tertiary structure of the PR8 ED 3o9s_A, which does not
form a strand–strand dimer, bears more similarity to 3d6r_A than to
the previously characterized PR8 ED structure 2gx9_A. Furthermore,
a comparison of each ED monomer solved to date with these two
archetypes (2gx9_A and 3d6r_A) showed that while no monomer
structure differed from either of the structures by more than 1.04 A˚,
all ED monomers involved in strand–strand contacts bore greater
homology to 2gx9_A than to 3d6r_A (Table 2). Therefore, it appears
to be likely that this orientation is induced by interactions at the
strand–strand interface and may not exist outside of this context. In
support of this view, examination of the NMR structure of an Udorn
effector domain (PDB entry 2kkz; Aramini et al., 2011) indicates that
the 3d6r_A conformation is adopted in all NMR states, while the
2gx9_A conformation is not present. While the W187R mutation
present within the monomer used to collect these NMR data is likely
to disrupt ED dimerization, it is located within the helix–helix
interface and is unlikely to influence any strand–strand interactions.
While it appears to be unlikely that the strand–strand dimer is the
predominant ED homodimer, the partial conservation of this inter-
face and the ability of contacts at this interface to induce confor-
mational changes are interesting and may indicate that this surface
may be utilized in other intermolecular interactions. Furthermore, the
observation that other sequences can form a -strand addition at this
interface, as seen in 3m5r, suggests that such -sheet augmentations
are unlikely to be restricted to the formation of a strand–strand
dimer. Therefore, it is possible to envisage similar interactions
existing between NS1 and one or more of the wide variety of factors
that it is known to bind to.
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Table 2
Analysis of NS1 ED-monomer homology.
Root-mean-square deviations (r.m.s.d.s) were calculated for each monomer with respect
to two archetypes, 2gx9_A and 3d6r_A, using PyMOL. Values in bold indicate the lower
r.m.s.d. relationship. Strain abbreviations are as follows: PR8, A/Puerto Rico/8/34;
Alb/76, A/Duck/Albany/60/76; Ud/72, A/Udorn/72; VN/04, A/Viet Nam/1203/2004;
Cal/04, A/California/07/2009.
Strain Structure (PDB
code_chain)
Strand–strand
dimer
2gx9_A
r.m.s.d. (A˚)
3d6r_A
r.m.s.d. (A˚)
Wild-type NS1 ED
PR8 2gx9_A Yes 0.00 0.91
PR8 2gx9_B Yes 0.30 0.87
PR8 3o9s_A No 0.85 0.73
PR8 3o9s_B No 0.85 0.60
PR8 3o9u_A Yes 0.57 0.72
PR8 3o9u_B Yes 0.55 0.63
PR8 3o9u_C Yes 0.56 0.63
PR8 3o9u_D Yes 0.57 0.72
PR8 3o9u_E Yes 0.55 0.63
PR8 3o9u_F Yes 0.55 0.63
PR8 3o9u_G Yes 0.57 0.63
PR8 3o9u_H Yes 0.57 0.63
PR8 3o9t_A No 0.61 0.58
PR8 3o9t_B No 0.59 0.57
Alb/76 3d6r_A No 0.91 0.00
Alb/76 3d6r_B No 0.98 0.31
Alb/76 3oa9_A No 0.98 0.37
Alb/76 3oa9_B No 0.81 0.52
Ud/72 3ee9_A No 0.87 0.52
Ud/72 3ee9_B No 0.63 0.59
Ud/72 3ee8_A No 0.87 0.52
Ud/72 3ee8_A No 0.84 0.53
VN/04 3f5t_A No 1.04 0.61
Cal/07 3m5r_A No 0.79 0.46
Cal/07 3m5r_B No 0.69 0.61
Cal/07 3m5r_D No 0.75 0.55
Cal/07 3m5r_E No 0.67 0.56
Cal/07 3m5r_F No 0.68 0.56
Cal/07 3m5r_G No 0.71 0.69
Mutant NS1 ED
PR8 (W187A) 3o9r_A Yes 0.59 0.82
PR8 (W187A) 3o9r_B Yes 0.56 0.79
PR8 (W187A) 3o9q_A Yes 0.56 0.66
PR8 (W187A) 3o9q_B Yes 0.61 0.64
PR8 (W187A) 3rvc_A Yes 0.49 0.69
Ud/72 (W187A) 3kwg_A No 0.92 0.49
Ud/72 (W187A) 3kwg_B No 0.81 0.43
Ud/72 (W187Y) 3kwi_A No 0.83 0.59
Ud/72 (W187Y) 3kwi_B No 0.65 0.51
NS1 ED in complex
PR8 (with p85) 3l4q_A No 1.04 0.52
PR8 (with p85) 3l4q_B No 1.05 0.58
Ud/72 (with CPSF30) 2rhk_A No 0.91 0.39
Ud/72 (with CPSF30) 2rhk_B No 0.96 0.47
NMR structures of NS1 domains
Ud/72 (W187R) 2kkz_A No 0.93 0.82
